News Daily News AHA Stats Show CV Health of Americans Remains Dire Michael O'Riordan January 28, 2025
News Daily News European Medicines Agency Investigating GLP-1 Drugs and Eye Disease L.A. McKeown January 21, 2025
News Daily News Misleading Statements Common in Online Ads for Compounded GLP-1s L.A. McKeown January 20, 2025
News Daily News Vascular Disease History Need Not Preclude Aspirin Withdrawal After HeartMate 3 Yael L. Maxwell January 15, 2025
News Daily News Global Commission Proposes ‘Radical’ Overhaul of Obesity Diagnosis L.A. McKeown January 14, 2025
News Daily News Global Study Shows Sugary Drinks Boosting Diabetes and CVD at Alarming Rates L.A. McKeown January 10, 2025
News Daily News Variety of GLP-1 Drugs Help People Without Diabetes Lose Weight: Review Todd Neale January 09, 2025
News Daily News Aircraft Noise Exposure Linked to ‘Thicker, Weaker, and Stiffer Hearts’ Yael L. Maxwell January 09, 2025
News Daily News Tirzepatide Gets FDA Approval for Sleep Apnea in Adults With Obesity L.A. McKeown December 23, 2024
News Daily News Obesity Trends May Be Going in the Right Direction for the First Time in a Decade L.A. McKeown December 18, 2024
News Daily News PREVENT Tool Accurately Predicts HF Risk, With ‘Strong’ ASCVD Overlap Yael L. Maxwell December 17, 2024
News Daily News FINEARTS-HF Analysis Supports Finerenone’s Value in HFpEF With Obesity L.A. McKeown December 13, 2024
News Daily News Could Pricey GLP-1 Drugs Cut Healthcare Costs? The Math Isn’t Simple L.A. McKeown December 09, 2024
News Daily News Tirzepatide Bests Semaglutide for Weight Loss: SURMOUNT-5 Top-line Results Michael O'Riordan December 04, 2024
News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Daily News Rural Counties Bore Brunt of Worsening CV Mortality During Pandemic Yael L. Maxwell November 15, 2024